Jamison Private Wealth Management, Inc. Gilead Sciences, Inc. Transaction History
Jamison Private Wealth Management, Inc.
- $823 Billion
- Q4 2025
A detailed history of Jamison Private Wealth Management, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Jamison Private Wealth Management, Inc. holds 31,727 shares of GILD stock, worth $3.94 Million. This represents 0.47% of its overall portfolio holdings.
Number of Shares
31,727
Previous 31,453
0.87%
Holding current value
$3.94 Million
Previous $3.49 Billion
11.54%
% of portfolio
0.47%
Previous 0.44%
Shares
10 transactions
Others Institutions Holding GILD
# of Institutions
2,386Shares Held
1.01BCall Options Held
8.58MPut Options Held
7.35M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...